Co-Authors
This is a "connection" page, showing publications co-authored by Rogier Sanders and Philip Brouwer.
Connection Strength
1.613
-
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection. Cell. 2021 03 04; 184(5):1188-1200.e19.
Score: 0.926
-
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science. 2020 08 07; 369(6504):643-650.
Score: 0.222
-
Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation. Biochemistry. 2021 07 13; 60(27):2153-2169.
Score: 0.060
-
Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva. Pathog Immun. 2021; 6(1):116-134.
Score: 0.059
-
Human Milk from Previously COVID-19-Infected Mothers: The Effect of Pasteurization on Specific Antibodies and Neutralization Capacity. Nutrients. 2021 May 13; 13(5).
Score: 0.059
-
High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages. Sci Transl Med. 2021 06 02; 13(596).
Score: 0.059
-
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity. Science. 2021 02 26; 371(6532).
Score: 0.058
-
Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity. Immunity. 2020 12 15; 53(6):1272-1280.e5.
Score: 0.057
-
An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain. Cell Rep. 2020 10 20; 33(3):108274.
Score: 0.057
-
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings. PLoS Pathog. 2020 09; 16(9):e1008817.
Score: 0.057